VMP 36030311000001108

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Natalizumab 300mg/15ml solution for infusion vials
BNF code 0802040W0AAAAAA
Virtual Therapeutic Moiety Natalizumab
Date identifier became valid 29 Oct 2018
Previous product identifier 414806008
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 19 Jan 2009
Previous name Natalizumab 300mg/15ml solution for injection vials
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 15.000
Unit dose form units ml
Unit dose unit of measure vial
Virtual Product Ingredient
Ingredient Natalizumab
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 20.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solutioninfusion.intravenous
Dose Form
Formulation Solution for infusion
Drug Route
Route Intravenous
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Tyruko 300mg/15ml concentrate for solution for infusion vials (Sandoz Ltd)
Tysabri 300mg/15ml concentrate for solution for infusion vials (Biogen Idec Ltd)
Virtual Medicinal Product Packs
Natalizumab 300mg/15ml solution for infusion vials 1 vial

dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.

Feedback